These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25402189)

  • 21. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Rivaroxaban Therapy on ROTEM Coagulation Parameters in Patients with Venous Thromboembolism.
    Chojnowski K; Górski T; Robak M; Treliński J
    Adv Clin Exp Med; 2015; 24(6):995-1000. PubMed ID: 26771971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.
    Reda S; Brügelmann A; Müller J; Oldenburg J; Pötzsch B; Rühl H
    Sci Rep; 2020 Jul; 10(1):12221. PubMed ID: 32699227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
    Favaloro EJ; Mohammed S; Curnow J; Pasalic L
    Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays.
    Hillarp A; Strandberg K; Gustafsson KM; Lindahl TL
    J Thromb Haemost; 2020 Aug; 18(8):1866-1873. PubMed ID: 32294291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.
    Genzen JR; Miller JL
    Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of lupus anticoagulant in the era of direct oral anticoagulants.
    Hoxha A; Banzato A; Ruffatti A; Pengo V
    Autoimmun Rev; 2017 Feb; 16(2):173-178. PubMed ID: 27988438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dilute Russell's viper venom time reagents in lupus anticoagulant testing: a well-considered choice.
    Depreter B; Devreese KM
    Clin Chem Lab Med; 2017 Jan; 55(1):91-101. PubMed ID: 27331311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa.
    Favaloro EJ; Gilmore G; Arunachalam S; Mohammed S; Baker R
    Thromb Res; 2019 Aug; 180():10-19. PubMed ID: 31158643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consultative Interpretation for Lupus Anticoagulant by Expert Pathologist Reduces False-Positive Rates in the Era of Direct Oral Anticoagulants.
    Vivero A; Kitahara S; Runge A; Volod O
    J Appl Lab Med; 2020 Jan; 5(1):73-82. PubMed ID: 31811080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated protein C resistance in patients following venous thromboembolism receiving rivaroxaban versus vitamin K antagonists: assessment using Russell viper venom time-based assay.
    Goralczyk T; Wojtowicz KB; Undas A
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):309-315. PubMed ID: 27636904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays.
    Hillarp A; Strandberg K; Baghaei F; Fagerberg Blixter I; Gustafsson KM; Lindahl TL
    Scand J Clin Lab Invest; 2018; 78(7-8):575-583. PubMed ID: 30278787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance Characteristics of DOAC-Remove for Neutralization of the Effects of Apixaban and Rivaroxaban in Lupus Anticoagulant Assays.
    Skaugen JM; Sayre C; Hassett AC; Chibisov I; Bontempo F; Meyer MP; Seheult JN
    Am J Clin Pathol; 2022 Mar; 157(3):457-469. PubMed ID: 34698336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay.
    Moore GW; Foxton E; Platton S; Yartey N; White D; MacDonald SG
    J Thromb Haemost; 2023 Dec; 21(12):3539-3546. PubMed ID: 37597725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
    Hong SK; Hwang SM; Kim JE; Kim HK
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Indirect- and Direct-Acting Anticoagulants on Lupus Anticoagulant Assays: A Large, Retrospective Study at a Coagulation Reference Laboratory.
    Seheult JN; Meyer MP; Bontempo FA; Chibisov I
    Am J Clin Pathol; 2017 Jun; 147(6):632-640. PubMed ID: 28525532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels.
    Francart SJ; Hawes EM; Deal AM; Adcock DM; Gosselin R; Jeanneret C; Friedman KD; Moll S
    Thromb Haemost; 2014 Jun; 111(6):1133-40. PubMed ID: 24401946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxaban.
    Gosselin RC; Adcock Funk DM; Taylor JM; Francart SJ; Hawes EM; Friedman KD; Moll S
    Arch Pathol Lab Med; 2014 Dec; 138(12):1680-4. PubMed ID: 25427046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical Considerations and Testing Nuances for the Detection of Lupus Anticoagulant: Do Low Phospholipid Screen Results, Assay Type, and Test Ratio Matter?
    Asakrah S; Davis R; Bhargava P
    Am J Clin Pathol; 2021 Nov; 156(6):1073-1082. PubMed ID: 34075395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.